CA
CAH.US Cardinal Health Inc
- Market cap
- USD 65.0B
- P/E
- 36.0x
- P/B
- 16.07x
- ROE
- -
- Dividend yield
- 0.76%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Sep 2026.
Is CAH.US undervalued?
Graham numberThe Graham number of Cardinal Health Inc cannot be estimated reliably (the estimate is too far from the market price).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Cardinal Health Inc fundamental analysis
No fundamental analysis for Cardinal Health Inc yet.
Cardinal Health Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Cardinal Health Inc
Cardinal Health, Inc. operates as a healthcare services and products company in the United States and internationally. It operates in two segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution. The company offers customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. It distributes branded and generic pharmaceutical, specialty p…
Full company profileCardinal Health Inc financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 1 quarter up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Cardinal Health Inc annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 130B | 137B | 146B | 153B | 162B | 181B | 205B | 227B | 223B | 254B | 270B |
| Gross Profit | 6.54B | 7.18B | 6.83B | 6.87B | 6.78B | 6.48B | 6.89B | 7.41B | 8.17B | 9.77B | 10.4B |
| Operating Income | 2.12B | 126M | 2.06B | -4.10B | 472M | -607M | 752M | 1.24B | 2.28B | 2.61B | 3.01B |
| EBITDA | 2.84B | 1.13B | 3.05B | -2.62B | 1.29B | 55.0M | 1.44B | 1.96B | 3.11B | 3.48B | 4.03B |
| Net Income | 1.29B | 256M | 1.36B | -3.69B | 611M | -938M | 330M | 852M | 1.56B | 1.71B | 2.22B |
| EPS | 4.03 | 0.81 | 4.53 | -13 | 2.08 | -3.36 | 1.26 | 3.45 | 6.45 | 7.23 | 9.51 |
| Balance Sheet | |||||||||||
| Total Assets | 40.1B | 40.0B | 41.0B | 40.8B | 44.5B | 43.9B | 43.3B | 45.1B | 53.1B | 57.3B | 59.5B |
| Total Liabilities | 33.3B | 33.9B | 34.6B | 39.0B | 42.7B | 44.6B | 46.3B | 48.3B | 55.8B | 60.0B | 62.4B |
| Shareholders' Equity | 6.81B | 6.06B | 6.33B | 1.79B | 1.79B | -709M | -2.96B | -3.21B | -2.78B | -2.88B | -3.03B |
| Cash & Short-term Investments | 6.88B | 1.76B | 2.53B | 2.77B | 3.41B | 4.72B | 4.08B | 5.13B | 3.87B | 4.86B | 5.26B |
| Total Debt | 10.4B | 9.01B | 8.03B | 6.78B | 6.72B | 5.81B | 5.18B | 5.61B | 9.35B | 9.95B | 8.82B |
| Cash Flow | |||||||||||
| Operating Cash Flow | 1.18B | 2.77B | 2.72B | 1.96B | 2.43B | 3.12B | 2.84B | 3.76B | 2.40B | 5.17B | 5.59B |
| Capital Expenditure | 387M | 384M | 328M | 375M | 400M | 387M | 481M | 511M | 547M | 649M | 628M |
| Free Cash Flow | 797M | 2.38B | 2.39B | 1.59B | 2.03B | 2.74B | 2.36B | 3.25B | 1.85B | 4.53B | 4.96B |
| Ratios | |||||||||||
| ROE | 18.9% | 4.2% | 21.5% | -206.4% | 34.1% | - | - | - | - | - | - |
| ROA | 3.2% | 0.6% | 3.3% | -9.1% | 1.4% | -2.1% | 0.8% | 1.9% | 2.9% | 3.0% | 3.7% |
| Net Profit Margin | 1.0% | 0.2% | 0.9% | -2.4% | 0.4% | -0.5% | 0.2% | 0.4% | 0.7% | 0.7% | 0.8% |
| Debt to Equity | 1.53x | 1.49x | 1.27x | 3.79x | 3.75x | - | - | - | - | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Cardinal Health Inc dividends
- Dividend yield
- 0.76%
- Forward dividend
- 2.06 USD
- Payout ratio
- 28.6%
- Ex-dividend date
- Oct 1, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2026 | USD 491M | 2.07 | 28.6% |
| 2025 | USD 494M | 2.04 | 31.6% |
| 2024 | USD 499M | 2.02 | 58.6% |
| 2023 | USD 525M | 2.00 | 159.1% |
| 2022 | USD 559M | 2.00 | - |
| 2021 | USD 573M | 1.95 | 93.8% |
| 2020 | USD 569M | 1.94 | - |
| 2019 | USD 577M | 1.92 | 42.3% |
| 2018 | USD 581M | 1.84 | 227.0% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 3:2 on Apr 23, 2001.
Who owns Cardinal Health Inc
- Insiders 0.29%
- Institutions 91.62%
- Public & others 8.10%
- Shares outstanding 231M
- Free float 231M
Top funds holding CAH.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| Vanguard MStar Total Stk Mkt Idx Invest | 7.38M | 3.19% | -0.83% | Sep 2026 |
| Vanguard 500 Index Investor | 6.11M | 2.64% | -1.79% | Sep 2026 |
| Vanguard MStar Mid Cap Index Instl | 4.98M | 2.15% | -1.69% | Sep 2026 |
| iShares Core S&P 500 ETF | 3.10M | 1.34% | +0.17% | Oct 2026 |
| Fidelity 500 Index | 3.02M | 1.31% | -0.58% | Sep 2026 |
| State Street® SPDR® S&P 500® ETF | 2.83M | 1.22% | -0.25% | Oct 2026 |
| Vanguard Equity-Income Inv | 2.27M | 0.98% | -13.75% | Sep 2026 |
| Vanguard MStar Value Index Investor | 2.22M | 0.96% | -0.98% | Sep 2026 |
| Vanguard Wellington Inv | 2.15M | 0.93% | -2.55% | Sep 2026 |
| State Street®HlthCrSelSectSPDR®ETF | 1.70M | 0.74% | +0.88% | Oct 2026 |
| iShares Large Cap Core Active ETF | 1.53M | 0.66% | +0.12% | Oct 2026 |
| Vanguard MStar Mid Cap Value ETF | 1.45M | 0.63% | -4.23% | Sep 2026 |
| Vanguard Dividend Growth Inv | 1.40M | 0.60% | -10.15% | Sep 2026 |
| Vanguard Dividend Appreciation ETF | 1.32M | 0.57% | -0.75% | Sep 2026 |
| Vanguard Institutional Index I | 1.23M | 0.53% | -1.71% | Sep 2026 |
| Vanguard Health Care Inv | 1.16M | 0.50% | -60.04% | Sep 2026 |
| iShares Russell Mid-Cap ETF | 994K | 0.43% | -0.06% | Oct 2026 |
| Vanguard High Dividend Yield ETF | 952K | 0.41% | +0.28% | Sep 2026 |
| Fidelity Mid Cap Index | 888K | 0.38% | -0.31% | Sep 2026 |
| VictoryShares Free Cash Flow ETF | 861K | 0.37% | +0.34% | Oct 2026 |
Top institutions holding CAH.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| BlackRock Inc | 26.5M | 11.46% | -7.03% | Jun 2026 |
| Vanguard Capital Management, LLC | 15.3M | 6.62% | +0.02% | Jun 2026 |
| Wellington Management Company LLP | 14.9M | 6.43% | +247.52% | Jun 2026 |
| Vanguard Portfolio Management, LLC | 13.7M | 5.94% | -0.11% | Jun 2026 |
| State Street Corp | 12.0M | 5.18% | -0.89% | Jun 2026 |
| Geode Capital Management, LLC | 6.47M | 2.80% | -1.64% | Jun 2026 |
| Amvescap Plc. | 4.74M | 2.05% | +35.03% | Jun 2026 |
| Morgan Stanley - Brokerage Accounts | 4.63M | 2.00% | -6.64% | Jun 2026 |
| WCM Investment Management | 4.11M | 1.78% | +2.64% | Jun 2026 |
| NORGES BANK | 3.73M | 1.61% | -3.11% | Jun 2026 |
| Bank of America Corp | 2.90M | 1.25% | +0.65% | Jun 2026 |
| Northern Trust Corp | 2.87M | 1.24% | +2.67% | Jun 2026 |
| JPMorgan Chase & Co | 2.67M | 1.15% | +15.20% | Jun 2026 |
| The Goldman Sachs Group Inc | 2.39M | 1.03% | +0.56% | Jun 2026 |
| T. Rowe Price Associates, Inc. | 2.25M | 0.97% | +19.95% | Jun 2026 |
| UBS Asset Mgmt Americas Inc | 2.22M | 0.96% | -4.21% | Jun 2026 |
| BNP Paribas Arbitrage, SA | 2.10M | 0.91% | +39.85% | Jun 2026 |
| FMR Inc | 2.07M | 0.89% | -51.30% | Jun 2026 |
| Victory Capital Management Inc. | 1.98M | 0.86% | +42.60% | Jun 2026 |
| Legal & General Group PLC | 1.85M | 0.80% | -9.44% | Jun 2026 |
Cardinal Health Inc company profile
- Company name
- Cardinal Health Inc
- Ticker
- CAH.US
- Exchange
- USA Stocks
- Listed since
- Dec 31, 1987
- Sector
- Healthcare
- Industry
- Health Care Providers & Services
- Employees
- 58,788
- Fiscal year end
- June
- Address
- 7000 Cardinal Place, Dublin, OH, United States, 43017
- Phone
- 614 757 5000
- Website
- cardinalhealth.com
About Cardinal Health Inc
Cardinal Health, Inc. operates as a healthcare services and products company in the United States and internationally. It operates in two segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution. The company offers customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. It distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The company also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; pharmacy management services to hospitals; operates pharmacies, including pharmacies in community health centers; and repackages generic pharmaceuticals and over-the-counter healthcare products. In addition, it manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compression, incontinence, nutritional delivery, and wound care products; single-use surgical drapes, gowns, and apparel products; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. Further, the company distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile and non-sterile procedure kits. Additionally, it manufactures, prepares, and delivers radiopharmaceuticals; and optimizes direct shipments through integrated technology solutions. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.
Cardinal Health Inc management
10- Mr. Jason M. HollarCEO & Director · born 1973
- Mr. Aaron E. Alt J.D.Chief Financial Officer · born 1972
- Ms. Jessica L. MayerChief Legal & Compliance Officer · born 1969
- Mr. Stephen M. MasonChief Executive Officer of GMPD segment · born 1971
- Ms. Deborah L. WeitzmanChief Executive Officer of Pharmaceutical & Specialty Solutions Segment · born 1965
- Ms. Mary C. SchererSenior VP & Chief Accounting Officer
- Mr. David FrostVice President of Investor Relations
- Ms. Valerie Christine PitteroffChief Human Resources Officer · born 1971
- Mr. Craig CowmanPresident of Biopharma Solutions & Strategic Sourcing
- Mr. Ben BrinkerPresident of Global Operations & Supply Chain